Advertisement

International Urology and Nephrology

, Volume 51, Issue 4, pp 723–727 | Cite as

ISPD guideline-driven retraining, exit site care and decreased peritonitis: a single-center experience in Israel

  • Yael EinbinderEmail author
  • Keren Cohen-Hagai
  • Pnina Shitrit
  • Tali Zitman-Gal
  • Daniel Erez
  • Sydney Benchetrit
  • Ze’ev Korzets
  • Andy Kotliroff
Nephrology - Original Paper

Abstract

Purpose

Evaluate the efficacy of retraining and catheter exit site care in reducing peritonitis rates.

Methods

This interventional study included all prevalent PD patients from 1/2009 to 12/2017 from a single center. Peritonitis rates and causative organisms were assessed and compared in three periods: (1) Before intervention (01/2009–12/2014), (2) after educational intervention: assessment of training process by infection control nurse and repeat training every 3 months, after each peritonitis episode and after hospitalizations > 2 weeks (01/2015–02/2016), and (3) in addition to the measures in period 2, an exit site care protocol including postoperative care, topical antibacterial therapy and nasal Staph aureus screening and eradication was implemented (03/2016–12/2017).

Results

The study included 201 patients (149 men, 52 women), mean age was 65.1 ± 12.6 years. After both interventions, including educational and exit site care strategies, peritonitis decreased significantly from 1.05 episodes per patient-year (n = 113) to 0.67 (n = 54); P = 0.017 between periods 1 and 3. The percentage of peritonitis-free patients increased from 27.4 to 52.4 and 55.6%, respectively (P = 0.001 between period 1 vs. 2 and period 1 vs. 3.). Coagulase-negative staph was the most common pathogen, causing 7.56 peritonitis episodes per year, followed by pseudomonas at 4.33 episodes annually and staph aureus at 3.44 episodes per year.

Conclusions

Enforcement of an educational program and strict adherence to an exit site care protocol was associated with a significant decrease in peritonitis rates.

Keywords

Peritonitis Peritoneal dialysis Exit site care Education and training 

Notes

Compliance with ethical standards

Conflict of interest

No conflict exists.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

References

  1. 1.
    Mehrotra R, Devuyst O, Davies SJ, Johnson DW (2016) The current state of peritoneal dialysis. J Am Soc Nephrol 27:3238–3252CrossRefGoogle Scholar
  2. 2.
    Johnson DW, Dent H, Hawley CM et al (2009) Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Am J Kidney Dis 53:290–297CrossRefGoogle Scholar
  3. 3.
    Cho Y, Johnson DW (2014) Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am J Kidney Dis 64:278–289CrossRefGoogle Scholar
  4. 4.
    Boudville N, Kemp A, Clayton P et al (2012) Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J Am Soc Nephrol 23:1398–1405CrossRefGoogle Scholar
  5. 5.
    Segal JH, Messana JM (2013) Prevention of peritonitis in peritoneal dialysis. Semin Dial 26:494–502CrossRefGoogle Scholar
  6. 6.
    Li PK, Szeto CC, Piraino B et al (2016) ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment. Perit Dial Int 36:481–508CrossRefGoogle Scholar
  7. 7.
    Szeto CC, Li PK, Johnson DW et al (2017) ISPD catheter-related infection recommendations: 2017 update. Perit Dial Int 37:141–154CrossRefGoogle Scholar
  8. 8.
    Hsieh YP, Chang CC, Wen YK, Chiu PF, Yang Y (2014) Predictors of peritonitis and the impact of peritonitis on clinical outcomes of continuous ambulatory peritoneal dialysis patients in Taiwan—10 years’ experience in a single center. Perit Dial Int 34:85–94CrossRefGoogle Scholar
  9. 9.
    Piraino B, Bernardini J, Brown E et al (2011) ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int 31:614–630CrossRefGoogle Scholar
  10. 10.
    Nessim SJ, Bargman JM, Austin PC, Nisenbaum R, Jassal SV (2009) Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database. Clin J Am Soc Nephrol 4:1195–1200CrossRefGoogle Scholar
  11. 11.
    Cleper R, Davidovits M, Kovalski Y, Samsonov D, Amir J, Krause I (2010) Peritonitis in a pediatric dialysis unit: local profile and implications. Isr Med Assoc J 12:348–352Google Scholar
  12. 12.
    Lanot A, Bechade C, Verger C, Fabre E, Vernier I, Lobbedez T (2017) Clusters of practice in peritoneal dialysis in France: data from the catheter section of the Rdplf. Perit Dial Int 38:89–97CrossRefGoogle Scholar
  13. 13.
    Nadeau-Fredette AC, Johnson DW, Hawley CM et al (2016) Center-specific factors associated with peritonitis risk-a multi-center registry analysis. Perit Dial Int 36:509–518CrossRefGoogle Scholar
  14. 14.
    Benjamin J, Ben-Ezer Gradus D, Mostoslavski M, Rapoport J, Chaimovitz C (1989) Peritonitis in continuous ambulatory peritoneal dialysis patients in southern Israel. Isr J Med Sci 25:699–702Google Scholar
  15. 15.
    Bending M, Mellotte G (1996) Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group. J Am Soc Nephrol 7: 2403–2408Google Scholar
  16. 16.
    Morton RL, Snelling P, Webster AC et al (2012) Dialysis modality preference of patients with CKD and family caregivers: a discrete-choice study. Am J Kidney Dis 60:102–111CrossRefGoogle Scholar
  17. 17.
    Figueiredo AE, Bernardini J, Bowes E et al (2016) A syllabus for teaching peritoneal dialysis to patients and caregivers. Perit Dial Int 36:592–605CrossRefGoogle Scholar
  18. 18.
    Russo R, Manili L, Tiraboschi G et al (2006) Patient re-training in peritoneal dialysis: why and when it is needed. Kidney Int 70:S127–132CrossRefGoogle Scholar
  19. 19.
    Bordin G, Casati M, Sicolo N, Zuccherato N, Eduati V (2007) Patient education in peritoneal dialysis: an observational study in Italy. J Ren Care 33:165–171CrossRefGoogle Scholar
  20. 20.
    Bender FH, Bernardini J, Piraino B (2006) Prevention of infectious complications in peritoneal dialysis: best demonstrated practices. Kidney Int 70:44–54CrossRefGoogle Scholar
  21. 21.
    Kopriva-Altfahrt G, Konig P, Mundle M et al (2009) Exit-site care in Austrian peritoneal dialysis centers—a nationwide survey. Perit Dial Int 29:330–339Google Scholar
  22. 22.
    Szeto CC, Chow KM, Kwan BC et al (2007) Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases. Clin J Am Soc Nephrol 2:245–251CrossRefGoogle Scholar
  23. 23.
    Govindarajulu S, Hawley CM, McDonald SP et al (2010) Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Perit Dial Int 30:311–319CrossRefGoogle Scholar
  24. 24.
    Siva B, Hawley CM, McDonald SP et al (2009) Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol 4:957–964CrossRefGoogle Scholar
  25. 25.
    Mehrotra R, Singh H (2013) Peritoneal dialysis-associated peritonitis with simultaneous exit-site infection. Clin J Am Soc Nephrol 8:126–129 discussion 129–130CrossRefGoogle Scholar
  26. 26.
    Cho Y, Badve SV, Hawley CM et al (2013) Effects of climatic region on peritonitis risk, microbiology, treatment, and outcomes: a multicenter registry study. Perit Dial Int 33:75–85CrossRefGoogle Scholar
  27. 27.
    Lim WH, Johnson DW, McDonald SP (2005) Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA. Nephrology (Carlton) 10:192–197CrossRefGoogle Scholar
  28. 28.
    McDonald SP, Collins JF, Rumpsfeld M, Johnson DW (2004) Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int 24:340–346Google Scholar
  29. 29.
    Benabed A, Bechade C, Ficheux M, Verger C, Lobbedez T (2016) Effect of assistance on peritonitis risk in diabetic patients treated by peritoneal dialysis: report from the French Language Peritoneal Dialysis Registry. Nephrol Dial Transplant 31:656–662CrossRefGoogle Scholar
  30. 30.
    Bevilacqua MU, Turnbull L, Saunders S et al (2017) Evaluation of a 12-month pilot of long-term and temporary assisted peritoneal dialysis. Perit Dial Int 37:307–313CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.Department of Nephrology and HypertensionMeir Medical CenterKfar SabaIsrael
  2. 2.Infection Control UnitMeir Medical CenterKfar SabaIsrael
  3. 3.Sackler Faculty of MedicineTel Aviv UniversityTel AvivIsrael

Personalised recommendations